United States · Investor

Genentech

Last cheque observed Jun 2012. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietGrowth equity

Series AGrowthSeries BAgriculturePredictive Analytics

Cheques on record
0%of best year0cheques in 12 months, 6 on record
Since the last cheque5260days00hrs00min00sec
Median round$28MRounds led0 of 6Sole investor2 roundsExits1 from the portfolioMostly inUnited States, 100%
Pitch Genentech

Genentech highlights

  1. 01

    6 rounds on record

  2. 02

    Mostly Series A and Growth: 50% of its rounds

  3. 03

    Sole investor in 2 rounds, median $58M

  4. 04

    1 exits from the portfolio

What they do

Type
Growth equity (from a list, unverified)
Cheque size
Not stated
Sectors
AgriculturePredictive Analytics
Based in
South San Francisco, United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first6 appearances

  1. 2012

    2 rounds

  2. Jun
    Rock HealthGrowth · US$4.0MWith 3 others
  3. Jan
    Constellation PharmaceuticalsSeries C · US · masshightech.com$95MSole investor
  4. 2007

    1 round

  5. May
    23andMeSeries A · US · 23andme.com$9.0MWith 4 others
  6. 2006

    1 round

  7. Oct
    TolerxSeries D · US$61MWith 11 others
  8. 2005

    1 round

  9. Dec
    GlobeImmuneSeries B · US$34MWith 7 others
  10. 2002

    1 round

  11. Mar
    TercicaSeries A · US$22MSole investor

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 11 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Exits from the portfolio

Companies it backed that were later bought or listed1 in all

TercicaBought by Ipsen$480MJun 2008

An exit counts when it came after the firm's first round in the company. From historical deal records.

Companies it bought

Acquisitions by the firm itself

Seragon Pharmaceuticals$725MJul 2014

Who they invest alongside

The investors most often in the same rounds as Genentech. A count of rooms they were both in, not a relationship either has claimed.

HealthCare VenturesGrowth equity2rounds together

Quick answers about Genentech

What does Genentech invest in?

Genentech invests most often at Series A and Growth (50% of the rounds on record), in sectors such as Agriculture and Predictive Analytics.

How active is Genentech?

6 investments on record, 0 of them in the last 12 months. The most recent was in Jun 2012.

How big are Genentech's cheques?

The median round it joins is $28M.

Does Genentech lead rounds?

Rarely, if at all: none of its 6 investments on record names it as the lead.

Where does Genentech invest?

Most of the companies it backs are in the United States (100%).

Is Genentech investing now?

No investments in the last 12 months; the latest was in Jun 2012.

Who does Genentech invest alongside?

Most often HealthCare Ventures (2 rounds together).

What kind of investor is Genentech?

Genentech is a growth equity firm based in South San Francisco, United States.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it